RI-1: A chemical inhibitor of RAD51 that disrupts Homologous recombination in human cells

Nucleic Acids Research

Volumn 40, Issue 15, 2012, Pages 7347-7357

  Budke, Brian ^a   Logan, Hillary L ^a   Kalin, Jay H ^b   Zelivianskaia, Anna S ^a   McGuire, William Cameron ^a   Miller, Luke L ^a   Stark, Jeremy M ^c   Kozikowski, Alan P ^b   Bishop, Douglas K ^a   Connell, Philip P ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^c CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTEINE; DNA; PROTEIN INHIBITOR; RAD51 PROTEIN; REPLICATION FACTOR A; RI 1; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; CELL SURVIVAL; CONTROLLED STUDY; CYTOTOXICITY; DNA BINDING; DNA CROSS LINKING; DNA DAMAGE; DRUG MECHANISM; DRUG PROTEIN BINDING; GENE CONVERSION; HIGH THROUGHPUT SCREENING; HOMOLOGOUS RECOMBINATION; HUMAN; HUMAN CELL; MASS SPECTROMETRY; OLIGOMERIZATION; PRIORITY JOURNAL; WESTERN BLOTTING;

ANTIBIOTICS, ANTINEOPLASTIC; CELL LINE, TUMOR; CROSS-LINKING REAGENTS; CYSTEINE; DNA DAMAGE; ENZYME INHIBITORS; HOMOLOGOUS RECOMBINATION; HUMANS; MITOMYCIN; MORPHOLINES; PROTEIN SUBUNITS; PYRROLES; RAD51 RECOMBINASE;

EID: 84867300763     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gks353     Document Type: Article

References (54)

1. Tebbs, R. S., Zhao, Y., Tucker, J. D., Scheerer, J. B., Siciliano, M. J., Hwang, M., Liu, N., Legerski, R. J. and Thompson, L. H. (1995) Correction of chromosomal instability and sensitivity to diverse mutagens by a cloned cDNA of the XRCC3 DNA repair gene. Proc. Natl Acad. Sci. USA, 92, 6354-6358.
2. Liu, N., Lamerdin, J. E., Tebbs, R. S., Schild, D., Tucker, J. D., Shen, M. R., Brookman, K. W., Siciliano, M. J., Walter, C. A., Fan, W. et al. (1998) XRCC2 and XRCC3, new human Rad51-family members, promote chromosome stability and protect against DNA cross-links and other damages. Mol. Cell, 1, 783-793.
3. Takata, M., Sasaki, M. S., Tachiiri, S., Fukushima, T., Sonoda, E., Schild, D., Thompson, L. H. and Takeda, S. (2001) Chromosome instability and defective recombinational repair in knockout mutants of the five Rad51 paralogs. Mol. Cell Biol., 21, 2858-2866.
4. Thompson, L. H. and Schild, D. (2001) Homologous recombinational repair of DNA ensures mammalian chromosome stability. Mutat. Res., 477, 131-153.
5. Martin, R. W., Orelli, B. J., Yamazoe, M., Minn, A. J., Takeda, S. and Bishop, D. K. (2007) RAD51 up-regulation bypasses BRCA1 function and is a common feature of BRCA1-deficient breast tumors. Cancer Res., 67, 9658-9665.
6. Vispe, S., Cazaux, C., Lesca, C. and Defais, M. (1998) Overexpression of Rad51 protein stimulates homologous recombination and increases resistance of mammalian cells to ionizing radiation. Nucleic Acids Res., 26, 2859-2864.
7. Slupianek, A., Schmutte, C., Tombline, G., Nieborowska-Skorska, M., Hoser, G., Nowicki, M. O., Pierce, A. J., Fishel, R. and Skorski, T. (2001) BCR/ABL regulates mammalian RecA homologs, resulting in drug resistance. Mol. Cell, 8, 795-806.
8. Bello, V. E., Aloyz, R. S., Christodoulopoulos, G. and Panasci, L. C. (2002) Homologous recombinational repair vis-a-vis chlorambucil resistance in chronic lymphocytic leukemia. Biochem. Pharmacol., 63, 1585-1588.
9. Hansen, L. T., Lundin, C., Spang-Thomsen, M., Petersen, L. N. and Helleday, T. (2003) The role of RAD51 in etoposide (VP16) resistance in small cell lung cancer. Int. J. Cancer, 105, 472-479.
10. Klein, H. L. (2008) The consequences of Rad51 overexpression for normal and tumor cells. DNA Repair, 7, 686-693.
11. Hine, C. M., Seluanov, A. and Gorbunova, V. (2008) Use of the Rad51 promoter for targeted anti-cancer therapy. Proc. Natl Acad. Sci. USA, 105, 20810-20815.
12. Maacke, H., Opitz, S., Jost, K., Hamdorf, W., Henning, W., Kruger, S., Feller, A. C., Lopens, A., Diedrich, K., Schwinger, E. et al. (2000) Over-expression of wild-type Rad51 correlates with histological grading of invasive ductal breast cancer. Int. J. Cancer, 88, 907-913.
13. Mitra, A., Jameson, C., Barbachano, Y., Sanchez, L., Kote-Jarai, Z., Peock, S., Sodha, N., Bancroft, E., Fletcher, A., Cooper, C. et al. (2009) Overexpression of RAD51 occurs in aggressive prostatic cancer. Histopathology, 55, 696-704.
14. Connell, P. P., Jayathilaka, K., Haraf, D. J., Weichselbaum, R. R., Vokes, E. E. and Lingen, M. W. (2006) Pilot study examining tumor expression of RAD51 and clinical outcomes in human head cancers. Int. J. Oncol., 28, 1113-1119.
15. Qiao, G. B., Wu, Y. L., Yang, X. N., Zhong, W. Z., Xie, D., Guan, X. Y., Fischer, D., Kolberg, H. C., Kruger, S. and Stuerzbecher, H. W. (2005) High-level expression of Rad51 is an independent prognostic marker of survival in non-small-cell lung cancer patients. Br. J. Cancer, 93, 137-143.
16. Takenaka, T., Yoshino, I., Kouso, H., Ohba, T., Yohena, T., Osoegawa, A., Shoji, F. and Maehara, Y. (2007) Combined evaluation of Rad51 and ERCC1 expressions for sensitivity to platinum agents in non-small cell lung cancer. Int. J. Cancer, 121, 895-900.
17. Russell, J. S., Brady, K., Burgan, W. E., Cerra, M. A., Oswald, K. A., Camphausen, K. and Tofilon, P. J. (2003) Gleevec-mediated inhibition of Rad51 expression and enhancement of tumor cell radiosensitivity. Cancer Res., 63, 7377-7383.
18. Ito, M., Yamamoto, S., Nimura, K., Hiraoka, K., Tamai, K. and Kaneda, Y. (2005) Rad51 siRNA delivered by HVJ envelope vector enhances the anti-cancer effect of cisplatin. J. Gene Med., 7, 1044-1052.
19. Jayathilaka, K., Sheridan, S. D., Bold, T. D., Bochenska, K., Logan, H. L., Weichselbaum, R. R., Bishop, D. K. and Connell, P. P. (2008) A chemical compound that stimulates the human homologous recombination protein RAD51. Proc. Natl Acad. Sci. USA, 105, 15848-15853.
20. Conway, A. B., Lynch, T. W., Zhang, Y., Fortin, G. S., Fung, C. W., Symington, L. S. and Rice, P. A. (2004) Crystal structure of a Rad51 filament. Nat. Struct. Mol. Biol., 11, 791-796.
21. Vaz, F., Hanenberg, H., Schuster, B., Barker, K., Wiek, C., Erven, V., Neveling, K., Endt, D., Kesterton, I., Autore, F. et al. (2010) Mutation of the RAD51C gene in a Fanconi anemia-like disorder. Nat. Genet., 42, 406-409.
22. Pierce, A. J., Johnson, R. D., Thompson, L. H. and Jasin, M. (1999) XRCC3 promotes homology-directed repair of DNA damage in mammalian cells. Genes Dev., 13, 2633-2638.
23. Bennardo, N., Cheng, A., Huang, N. and Stark, J. M. (2008) Alternative-NHEJ is a mechanistically distinct pathway of mammalian chromosome break repair. PLoS Genet., 4, e1000110.
24. Kowalczykowski, S. C., Paul, L. S., Lonberg, N., Newport, J. W., McSwiggen, J. A. and von Hippel, P. H. (1986) Cooperative and noncooperative binding of protein ligands to nucleic acid lattices: experimental approaches to the determination of thermodynamic parameters. Biochemistry, 25, 1226-1240.
25. Paques, F. and Haber, J. E. (1999) Multiple pathways of recombination induced by double-strand breaks in Saccharomyces cerevisiae. Microbiol. Mol. Biol. Rev., 63, 349-404.
26. Symington, L. S. (2002) Role of RAD52 epistasis group genes in homologous recombination and double-strand break repair. Microbiol. Mol. Biol. Rev., 66, 630-670.
27. Mansour, W. Y., Schumacher, S., Rosskopf, R., Rhein, T., Schmidt-Petersen, F., Gatzemeier, F., Haag, F., Borgmann, K., Willers, H. and Dahm-Daphi, J. (2008) Hierarchy of nonhomologous end-joining, single-strand annealing and gene conversion at site-directed DNA double-strand breaks. Nucleic Acids Res., 36, 4088-4098.
28. Stark, J. M., Pierce, A. J., Oh, J., Pastink, A. and Jasin, M. (2004) Genetic steps of mammalian homologous repair with distinct mutagenic consequences. Mol. Cell Biol., 24, 9305-9316.
29. Lipinski, C. A., Lombardo, F., Dominy, B. W. and Feeney, P. J. (2001) Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Deliv. Rev., 46, 3-26.
30. Smith, M. E., Schumacher, F. F., Ryan, C. P., Tedaldi, L. M., Papaioannou, D., Waksman, G., Caddick, S. and Baker, J. R. (2010) Protein modification, bioconjugation, and disulfide bridging using bromomaleimides. J. Am. Chem. Soc., 132, 1960-1965.
31. Ryan, C. P., Smith, M. E., Schumacher, F. F., Grohmann, D., Papaioannou, D., Waksman, G., Werner, F., Baker, J. R. and Caddick, S. (2011) Tunable reagents for multi-functional bioconjugation: reversible or permanent chemical modification of proteins and peptides by control of maleimide hydrolysis. Chem. Commun., 47, 5452-5454.
32. Pellegrini, L., Yu, D. S., Lo, T., Anand, S., Lee, M., Blundell, T. L. and Venkitaraman, A. R. (2002) Insights into DNA recombination from the structure of a RAD51-BRCA2 complex. Nature, 420, 287-293.
33. Wu, Y., He, Y., Moya, I. A., Qian, X. and Luo, Y. (2004) Crystal structure of archaeal recombinase RADA: a snapshot of its extended conformation. Mol. Cell, 15, 423-435.
34. Wu, Y., Qian, X., He, Y., Moya, I. A. and Luo, Y. (2005) Crystal structure of an ATPase-active form of Rad51 homolog from Methanococcus voltae. Insights into potassium dependence. J. Biol. Chem., 280, 722-728.
35. Bishop, D. K. (1994) RecA homologs Dmc1 and Rad51 interact to form multiple nuclear complexes prior to meiotic chromosome synapsis. Cell, 79, 1081-1092.
36. Sigurdsson, S., Van Komen, S., Bussen, W., Schild, D., Albala, J. S. and Sung, P. (2001) Mediator function of the human Rad51B-Rad51C complex in Rad51/RPA-catalyzed DNA strand exchange. Genes Dev., 15, 3308-3318.
37. Conilleau, S., Takizawa, Y., Tachiwana, H., Fleury, F., Kurumizaka, H. and Takahashi, M. (2004) Location of tyrosine 315, a target for phosphorylation by cAbl tyrosine kinase, at the edge of the subunit-subunit interface of the human Rad51 filament. J. Mol. Biol., 339, 797-804.
38. Krejci, L., Damborsky, J., Thomsen, B., Duno, M. and Bendixen, C. (2001) Molecular dissection of interactions between Rad51 and members of the recombination-repair group. Mol. Cell Biol., 21, 966-976.
39. Dupre, A., Boyer-Chatenet, L., Sattler, R. M., Modi, A. P., Lee, J. H., Nicolette, M. L., Kopelovich, L., Jasin, M., Baer, R., Paull, T. T. et al. (2008) A forward chemical genetic screen reveals an inhibitor of the Mre11-Rad50-Nbs1 complex. Nat. Chem. Biol., 4, 119-125.
40. Rass, E., Grabarz, A., Plo, I., Gautier, J., Bertrand, P. and Lopez, B. S. (2009) Role of Mre11 in chromosomal nonhomologous end joining in mammalian cells. Nat. Struct. Mol. Biol., 16, 819-824.
41. Ishida, T., Takizawa, Y., Kainuma, T., Inoue, J., Mikawa, T., Shibata, T., Suzuki, H., Tashiro, S. and Kurumizaka, H. (2009) DIDS, a chemical compound that inhibits RAD51-mediated homologous pairing and strand exchange. Nucleic Acids Res., 37, 3367-3376.
42. Takaku, M., Kainuma, T., Ishida-Takaku, T., Ishigami, S., Suzuki, H., Tashiro, S., van Soest, R. W., Nakao, Y. and Kurumizaka, H. (2011) Halenaquinone, a chemical compound that specifically inhibits the secondary DNA binding of RAD51. Genes Cells, 16, 427-436.
43. Huang, F., Motlekar, N. A., Burgwin, C. M., Napper, A. D., Diamond, S. L. and Mazin, A. V. (2011) Identification of specific inhibitors of human RAD51 recombinase using high-throughput screening. ACS Chem. Biol., 6, 628-635.
44. Huang, F., Mazin, O. M., Zentner, I. J., Cocklin, S. and Mazin, A. V. (2012) Inhibition of homologous recombination in human cells by targeting RAD51 recombinase. J. Med. Chem., 55, 3011-3020.
45. Connell, P. P., Siddiqui, N., Hoffman, S., Kuang, A., Khatipov, E. A., Weichselbaum, R. R. and Bishop, D. K. (2004) A hot spot for RAD51C interactions revealed by a peptide that sensitizes cells to cisplatin. Cancer Res., 64, 3002-3005.
46. Chen, C. F., Chen, P. L., Zhong, Q., Sharp, Z. D. and Lee, W. H. (1999) Expression of BRC repeats in breast cancer cells disrupts the BRCA2-Rad51 complex and leads to radiation hypersensitivity and loss of G (2)/M checkpoint control. J. Biol. Chem., 274, 32931-32935.
47. Nomme, J., Renodon-Corniere, A., Asanomi, Y., Sakaguchi, K., Stasiak, A. Z., Stasiak, A., Norden, B., Tran, V. and Takahashi, M. (2010) Design of potent inhibitors of human RAD51 recombinase based on BRC motifs of BRCA2 protein: modeling and experimental validation of a chimera peptide. J. Med. Chem., 53, 5782-5791.
48. Martinez, S. F., Renodon-Corniere, A., Nomme, J., Eveillard, D., Fleury, F., Takahashi, M. and Weigel, P. (2010) Targeting human Rad51 by specific DNA aptamers induces inhibition of homologous recombination. Biochimie, 92, 1832-1838.
49. Ohnishi, T., Taki, T., Hiraga, S., Arita, N. and Morita, T. (1998) In vitro and in vivo potentiation of radiosensitivity of malignant gliomas by antisense inhibition of the RAD51 gene. Biochem. Biophys. Res. Commun., 245, 319-324.
50. Collis, S. J., Tighe, A., Scott, S. D., Roberts, S. A., Hendry, J. H. and Margison, G. P. (2001) Ribozyme minigene-mediated RAD51 down-regulation increases radiosensitivity of human prostate cancer cells. Nucleic Acids Res., 29, 1534-1538.
51. Hegan, D. C., Lu, Y., Stachelek, G. C., Crosby, M. E., Bindra, R. S. and Glazer, P. M. (2010) Inhibition of poly (ADP-ribose) polymerase down-regulates BRCA1 and RAD51 in a pathway mediated by E2F4 and p130. Proc. Natl Acad. Sci. USA, 107, 2201-2206.
52. Ko, J. C., Tsai, M. S., Kuo, Y. H., Chiu, Y. F., Weng, S. H., Su, Y. C. and Lin, Y. W. (2011) Modulation of Rad51, ERCC1, and thymidine phosphorylase by emodin result in synergistic cytotoxic effect in combination with capecitabine. Biochem. Pharmacol., 81, 680-690.
53. Welsh, J. W., Mahadevan, D., Ellsworth, R., Cooke, L., Bearss, D. and Stea, B. (2009) The c-Met receptor tyrosine kinase inhibitor MP470 radiosensitizes glioblastoma cells. Radiat. Oncol., 4, 69.
54. Parsels, L. A., Morgan, M. A., Tanska, D. M., Parsels, J. D., Palmer, B. D., Booth, R. J., Denny, W. A., Canman, C. E., Kraker, A. J., Lawrence, T. S. et al. (2009) Gemcitabine sensitization by checkpoint kinase 1 inhibition correlates with inhibition of a Rad51 DNA damage response in pancreatic cancer cells. Mol. Cancer Ther., 8, 45-54.